{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:19:41Z","timestamp":1793740781577,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Develco Pharma Schweiz AG, Pratteln, Switzerland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jpba.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T09:31:04Z","timestamp":1504863064000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection"],"prefix":"10.1016","volume":"146","author":[{"given":"Georg M.","family":"Fassauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Mode\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.09.007_bib0005","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jpba.2017.09.007_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2017.09.007_bib0015","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.0078","article-title":"Use of ketamine in clinical practice \u2013 a time for optimism and caution","volume":"74","author":"Zorumski","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0025","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4088\/JCP.v69n0610","article-title":"Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depression","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0040","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","article-title":"(R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine","volume":"82","author":"Yang","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpba.2017.02.035","article-title":"Quantitative chiral and achiral determination of ketamine and its metabolites by LC\u2013MS\/MS in human serum, urine and fecal samples","volume":"139","author":"Hasan","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.09.007_bib0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2017.09.007_bib0055","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1586\/14737175.2014.971760","article-title":"What is hydroxynorketamine and what can it bring to neurotherapeutics?","volume":"14","author":"Singh","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jpba.2017.09.007_bib0060","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.biopsych.2016.06.029","article-title":"Antidepressant actions of ketamine versus hydroxynorketamine","volume":"81","author":"Collingridge","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0065","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.biopsych.2016.08.039","article-title":"Reply to: antidepressant actions of ketamine versus hydroxynorketamine","volume":"81","author":"Zanos","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpba.2017.09.007_bib0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2885.1991.tb00825.x","article-title":"Enantioselective N-demethylation of ketamine in the horse","volume":"14","author":"Delatour","year":"1991","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.09.007_bib0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0378-4347(91)80350-L","article-title":"Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma","volume":"568","author":"Geisslinger","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2017.09.007_bib0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0378-4347(95)00545-5","article-title":"Determination of ketamine and norketamine enantiomers in plasma by solid-phase extraction and high-performance liquid chromatography","volume":"678","author":"Svensson","year":"1996","journal-title":"J. Chromatogr. B: Biomed. Appl."},{"key":"10.1016\/j.jpba.2017.09.007_bib0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bja\/70.6.666","article-title":"Pharmacokinetics and pharmacodynamics of ketamine enantiomers insurgical patients using a stereoselective analytical method","volume":"70","author":"Geisslinger","year":"1993","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jpba.2017.09.007_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0009-9236(95)90194-9","article-title":"Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers","volume":"58","author":"Hartvig","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2017.09.007_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)00331-5","article-title":"Stereoselective high-performance liquid chromatographic determination of ketamine and its active metabolite, norketamine, in human plasma","volume":"746","author":"Yanagihara","year":"2000","journal-title":"J. Chromatogr. B: Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2017.09.007_bib0100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000542-197204000-00016","article-title":"A gas chromatographic assay for ketamine in human plasma","volume":"36","author":"Chang","year":"1972","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpba.2017.09.007_bib0105","first-page":"260","article-title":"Pharmacokinetics of ketamine in man","volume":"24","author":"Wieber","year":"1975","journal-title":"Anaesthesist"},{"key":"10.1016\/j.jpba.2017.09.007_bib0110","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/dmd.32.8.786","article-title":"Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2017.09.007_bib0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0378-4347(00)81901-5","article-title":"Rapid gas chromatographic analysis of plasma levels of ketamine and major metabolites employing either nitrogen selective or mass spectroscopic detection","volume":"146","author":"Davisson","year":"1978","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2017.09.007_bib0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.chroma.2012.09.058","article-title":"A novel derivatization approach for determination of ketamine in urine and plasma by gaschromatography-mass spectrometry","volume":"1264","author":"Lian","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.09.007_bib0125","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/elps.200500059","article-title":"Characterization of the stereoselective biotransformation of ketamine to norketamine via determination of their enantiomers in equine plasma by capillary electrophoresis","volume":"26","author":"Theurillat","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2017.09.007_bib0130","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/elps.200600820","article-title":"Enantioselective analysis of ketamine and its metabolites in equine plasma and urine by CE with multiple isomer sulfated beta-CD","volume":"28","author":"Theurillat","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2017.09.007_bib0135","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/elps.200900221","article-title":"CE provides evidence of the stereoselective hydroxylation of norketamine in equines","volume":"30","author":"Schmitz","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2017.09.007_bib0140","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/elps.201400093","article-title":"Development of a method for analysis of ketamine and norketamine enantiomers in equine brain and cerebrospinal fluid by capillary electrophoresis","volume":"35","author":"Theurillat","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpba.2017.09.007_bib0145","first-page":"74","article-title":"Pharmaceutical and forensic drug applications of chiral supercritical fluid chromatography","volume":"56","author":"P\u0142otka","year":"2014","journal-title":"TrAC"},{"key":"10.1016\/j.jpba.2017.09.007_bib0150","first-page":"17","article-title":"Core-shell particles lead the way to renewing high-performance liquid chromatography","volume":"64","author":"Gonz\u00e1lez-Ruiz","year":"2015","journal-title":"TrAC"},{"key":"10.1016\/j.jpba.2017.09.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2017.03.059","article-title":"Simultaneous analysis of nucleobases, nucleosides and ginsenosides in ginseng extracts using supercritical fluid chromatography coupled with single quadrupole mass spectrometry","author":"Huang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.09.007_bib0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0021-9673(93)83211-A","article-title":"Validation of the aromatic ring distribution in diesel fuel refinery streams by supercritical fluid chromatography and mass spectrometry","volume":"637","author":"Chen","year":"1993","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.09.007_bib0165","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1039\/C7AY00779E","article-title":"Supercritical fluid (CO2) chromatography for quantitative determination of selected cancer therapeutic drugs in the prescence of potential impurities in injection formulations","volume":"9","author":"Rao","year":"2017","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2017.09.007_bib0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.aca.2016.08.012","article-title":"Quantification of the neurotransmitters melatonin and N-acetyl-serotonin in human serum by supercritical fluid chromatography coupled with tandem mass spectrometry","volume":"937","author":"Wolrab","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2017.09.007_bib0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.talanta.2016.08.077","article-title":"Stereoselective quantification of triticonazole in vegetables by supercritical fluid chromatography","volume":"164","author":"Tan","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2017.09.007_bib0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpba.2014.09.036","article-title":"Development and validation of a supercritical fluid chromatography method for the direct determination of enantiomeric purity of provitamin B5 in cosmetic formulations with mass spectrometric detection","volume":"102","author":"Khater","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.09.007_bib0185","unstructured":"European Medicines Agency, Guideline on Bioanalytical Method Validation, Reference number EMEA\/CHMP\/EWP\/192217\/2009 Rev.1 Corr.2** (Lastupdated 2015), Online Access."},{"key":"10.1016\/j.jpba.2017.09.007_bib0190","series-title":"Guidance for the Industry: Bioanalytical Method Validation, Draft Guidance Revision 1","author":"Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.jpba.2017.09.007_bib0195","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1016\/j.chroma.2011.10.082","article-title":"Evaluation of the chiral recognition properties as well as the column performance of four chiral stationary phases based on cellulose (3,5-dimethylphenylcarbamate) by parallel HPLC and SFC","volume":"1218","author":"Nelander","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.09.007_bib0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.chroma.2004.04.060","article-title":"Effect of amine mobile phase additives on chiral subcritical fluid chromatography using polysaccharide stationary phases","volume":"1041","author":"Ye","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2017.09.007_bib0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.forsciint.2004.03.031","article-title":"Use of SPE and LC\/TIS\/MS\/MS for rapid detection and quantitation of ketamine and its metabolite, norketamine, in urine","volume":"147","author":"Wang","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2017.09.007_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jpba.2008.05.008","article-title":"Determination of ketamine and norketamine in plasma by micro-liquid chromatography-mass spectrometry","volume":"48","author":"Legrand","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2017.09.007_bib0215","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.talanta.2010.08.005","article-title":"A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome","volume":"82","author":"Moaddel","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2017.09.007_bib0220","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/rcm.6997","article-title":"Improved identification of multiple drugs of abuse and relative metabolites in urine samples using liquid chromatography\/triple quadrupole mass spectrometry coupled with a library search","volume":"28","author":"Lin","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517318095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517318095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T17:39:13Z","timestamp":1535391553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517318095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":44,"alternative-id":["S0731708517318095"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.09.007","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}